Reproducibility in Research – Biotech and Pharma Preclinical Stage

The crisis of Reproducibility in Research refers to the fact that almost 3 out of 4 scientists struggle to reproduce their own results.

This results in lost time, money and failures to earn Investigational New Drug (IND) approval required by FDA before advancing a product to Phase 1 clinical trials.

Below are some articles to get you started.

Solutions to Reproducibility in Research

Request a Corporate Consultation

Fill out my online form.